Cytokinetics (CYTK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

52.220
+0.200+0.38%

Close Nov 27 16:00 ET

51.190
-1.030-1.97%

Post 20:01 ET

6.16BMarket Cap-9706P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

RBC Capital Sticks to Its Buy Rating for Cytokinetics (CYTK)
TipRanks20:47 ET · Ratings
Insider Sale: Director at $CYTK (CYTK) Sells 742 Shares
Quiver QuantitativeNov 26 17:46 ET
Calculating The Intrinsic Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
Simply Wall StNov 26 08:45 ET
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Zacks Nov 22 13:00 ET
Cytokinetics Price Target Raised to $103 From $99 at Mizuho
Yahoo FinanceNov 22 06:51 ET
Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
Yahoo FinanceNov 21 17:39 ET

Comments

Sean Parker

Nov 19 02:56

$Cytokinetics (CYTK.US)$
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...